FDA warns of potential rare nerve complication with Johnson & Johnson coronavirus vaccine
FDA warns of potential rare nerve complication with Johnson & Johnson coronavirus vaccine AP Matt Rourke/AP Federal health officials are investigating the possibility that Johnson & Johnson's coronavirus vaccine might slightly raise the risk of a rare neurological complication known as Guillain-Barré syndrome By Amanda Sealy, John Bonifield and Maggie Fox, CNN The US Food and Drug Administration updated the label on Johnson & Johnson’s coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome. While the FDA said ...